NEEMA Published Papers – Viral Hepatitis

Toy M, Hutton D, Harris AM, Nelson N, Salomon JA, So S. Cost-Effectiveness of One-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United Statesexternal icon. Clinical Infectious Diseases. 2021 May 6:ciab405.

Assoumou SA, Nolen S, Hagan L, Wang J, Eftekhari Yazdi G, Thompson WW, Mayer KH, Puro J, Zhu L, Salomon JA, Linas BP. Hepatitis C Management at Federally Qualified Health Centers during the Opioid Epidemic: A Cost-Effectiveness Studyexternal icon. American Journal of Medicine. 2020 Nov;133(11):e641-e658.

Zhu L, Menzies NA, Wang J, Linas BP, Goodreau SM, Salomon JA. Estimation and correction of bias in network simulations based on respondent-driven sampling dataexternal icon. Scientific Reports. 2020 Apr 14;10(1):6348. doi: 10.1038/s41598-020-63269-0. PMID: 32286412; PMCID: PMC7156755.

Assoumou SA, Wang J, Nolen S, Eftekhari Yazdi G, Mayer KH, Puro J, Salomon JA, Linas BP. HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemicexternal icon. J Gen Intern Med. 2020 May;35(5):1477-1483.

Marseille E, Harris AM, Horvath H, Parriott A, Malekinejad M, Nelson NP, Van Handel M, Kahn JG. Hepatitis B prevalence association with sexually transmitted infections: a systematic review and meta-analysisexternal icon. Sex Health. 2021 Jun 29.

Epstein RL, Wang J, Hagan L, Mayer KH, Puro J, Linas BP, Assoumou SA. Hepatitis C Virus Antibody Testing Among 13-to 21-Year-Olds in a Large Sample of US Federally Qualified Health Centersexternal icon. Jama. 2019 Dec 10;322(22):2245-8.

Bellerose M, Zhu L, Hagan LM, Thompson WW, Randall LM, Malyuta Y, Salomon JA, Linas BP. A review of network simulation models of hepatitis C virus and HIV among people who inject drugsexternal icon. International Journal of Drug Policy. 2021 Feb: 88:102580.

Assoumou SA, Tasillo A, Vellozzi C, Eftekhari Yazdi G, Wang J, Nolen S, Hagan L, Thompson W, Randall LM, Strick L, Salomon JA, Linas, BP. Cost-effectiveness and Budgetary Impact of Hepatitis C Virus Testing, Treatment, and Linkage to Care in U.S. Prisonsexternal icon. Clinical InfectiousDiseases. 2020 May 17;70(7):1388-1396.

Tasillo A, Eftekhari GY, Nolen S, Schillie S, Vellozzi C, Epstein R, Randall L, Salomon JA, Linas BP. Short-Term Effects and Long-Term Cost-Effectiveness of Universal Hepatitis C Virus Testing in Prenatal Careexternal icon. Obstetrics and gynecology. 2019 Feb 1;133(2):289-300.

Assoumou SA, Wang J, Tasillo A, Yazdi GE, Tsui JI, Strick L, Linas BP. Hepatitis C Testing and Patient Characteristics in Washington State’s Prisons Between 2012 and 2016external icon. American journal of preventive medicine. 2019 Jan 1;56(1):8-16.

Chahal HS, Peters MG, Harris AM, McCabe D, Volberding P, Kahn JG. Cost-effectiveness of Hepatitis B Virus Infection Screening and Treatment or Vaccination in 6 High-risk Populations in the United Statesexternal icon. Open Forum Infectious Diseases. 2018 Dec 26;6(1):ofy353. Accessed 1/21/2019.

Epstein RL, Sabharwal V, Wachman EM, Saia KA, Vellozzi C, Hariri S, Linas BP. Perinatal transmission of hepatitis C virus: defining the cascade of careexternal icon The Journal of pediatrics. 2018 Dec 1;203:34-40.

Rosenberg E.S., Rosenthal E.M., Hall E., Barker, L., Hofmeister, M.G., Sullivan, P.S., Dietz. P., Mermin, J., Ryerson, B. Prevalence of Hepatitis C Virus Infection in US States and the District of Columbia, 2013 to 2016external iconJAMA Network Open. 2018;1(8):e186371. Accessed 12/21/2018.

Hall EW, Rosenberg ES, Trigg M, Nelson N, Schillie S. Cost Analysis of Single-Dose Hepatitis B Revaccination Among Infants Born to Hepatitis B Surface Antigen-Positive Mothers and Not Responding to the Initial Vaccine Seriesexternal icon. Public Health Reports. 2018 April 17. Accessed 4/18/2018.

Barocas JA, Tasillo A, Eftekhari G, Wang J, Vellozzi C, Hariri S, Isenhour C, Randall L, Ward JW, Mermin J, Salomon JA, Linas BP. Population Level Outcomes and Cost-Effectiveness of Expanding the Recommendation for Age-Based Hepatitis C Testing in the United Statesexternal icon, Clinical Infectious Diseases. 2018 Feb. 6. Accessed 2/9/2018.

Barocas JA, Wang J, White LF, Tasillo A, Salomon JA, Freedberg KA, Linas BP. Hepatitis C Testing Increased Among Baby Boomers Following The 2012 Change To CDC Testing Recommendationsexternal icon. Health Affairs 2017 36(12), 2142-2150. Accessed 2/9/2018.

Rosenberg ES, Hall EW, Sullivan PS, Sanchez TH, Workowski KA, Ward WW, Holtzman D. Estimation of State-level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010external icon. Clinical Infectious Diseases. 2017 Jun 1;64(11):1573-81. Accessed 4/26/2017.

Hankin-Wei A, Rein DB, Hernandez-Romieu A, Kennedy MJ, Bulkow L, Rosenberg E, Trigg M, Nelson NP. Cost-effectiveness Analysis of Catch-up Hepatitis A Vaccination Among Unvaccinated/Partially-Vaccinated Childrenexternal icon. Vaccine. 2016;34(35):4243-4249. Accessed 9/6/2016.

CDC led/CAMP Supported Publication

Hofmeister, M. G., Rosenthal, E. M., Barker, L. K., Rosenberg, E. S., Barranco, M. A., Hall, E. W., Edlin, B. R., Mermin, J. , Ward, J. W. and Blythe Ryerson, A., “Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013‐2016external icon”. Hepatology. (2018). Accessed 11/7/2018.

Get Tested - Search for HIV Testing Services
Atlas Plus - Explore Interactive CDC Data
CDC 24/7 - Protecting America's Safety, Health, and Security
Page last reviewed: August 19, 2021